Cargando…
Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice
Inflammatory bowel disease (IBD) refers to disorders involving chronic inflammation of the gastrointestinal tract. Well-established treatments for IBD have not yet to be suggested. To address this gap, we investigated the effects of co-administration of Lactobacillus gasseri (L. gasseri) KBL697 and...
Autores principales: | Han, Dae Hee, Kim, Woon-ki, Lee, Cheonghoon, Park, SungJun, Lee, Kiuk, Jang, Sung Jae, Ko, GwangPyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187735/ https://www.ncbi.nlm.nih.gov/pubmed/35688918 http://dx.doi.org/10.1038/s41598-022-13753-6 |
Ejemplares similares
-
Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota
por: Kim, Woon-Ki, et al.
Publicado: (2020) -
Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis
por: Kim, Woon-Ki, et al.
Publicado: (2019) -
Lactobacillus paracasei treatment modulates mRNA expression in macrophages
por: Han, Dae Hee, et al.
Publicado: (2020) -
Improved real-time quantitative reverse transcription PCR detection of norovirus following removal of inhibitors
por: Park, SungJun, et al.
Publicado: (2021) -
Oral Microbiota: Microbial Biomarkers of Metabolic Syndrome Independent of Host Genetic Factors
por: Si, Jiyeon, et al.
Publicado: (2017)